Free Trial

Zacks Research Expects Increased Earnings for Raymond James

Raymond James logo with Finance background

Raymond James (NYSE:RJF - Free Report) - Equities researchers at Zacks Research raised their Q3 2025 earnings per share estimates for Raymond James in a note issued to investors on Wednesday, January 15th. Zacks Research analyst R. Department now expects that the financial services provider will earn $2.61 per share for the quarter, up from their previous forecast of $2.60. The consensus estimate for Raymond James' current full-year earnings is $10.99 per share.

Raymond James (NYSE:RJF - Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.95 earnings per share for the quarter, beating analysts' consensus estimates of $2.41 by $0.54. Raymond James had a return on equity of 19.30% and a net margin of 13.86%. The business had revenue of $3.46 billion for the quarter, compared to analysts' expectations of $3.32 billion. During the same quarter in the prior year, the business earned $2.13 EPS. The firm's revenue for the quarter was up 13.4% on a year-over-year basis.

A number of other research analysts have also commented on the stock. The Goldman Sachs Group upgraded shares of Raymond James from a "neutral" rating to a "buy" rating and upped their price target for the company from $161.00 to $185.00 in a research note on Monday, January 6th. TD Cowen upped their target price on Raymond James from $128.00 to $150.00 and gave the company a "hold" rating in a research report on Wednesday, October 30th. Morgan Stanley increased their target price on Raymond James from $132.00 to $145.00 and gave the stock an "equal weight" rating in a research note on Tuesday, October 29th. Citigroup boosted their price target on Raymond James from $145.00 to $170.00 and gave the company a "neutral" rating in a research note on Friday, January 10th. Finally, Jefferies Financial Group increased their price objective on Raymond James from $123.00 to $126.00 and gave the stock a "hold" rating in a research report on Friday, October 4th. Nine investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $156.09.

Read Our Latest Analysis on RJF

Raymond James Stock Performance

Shares of RJF traded up $2.10 during trading hours on Friday, hitting $167.00. The company had a trading volume of 1,389,160 shares, compared to its average volume of 1,122,969. The business has a fifty day moving average of $160.60 and a 200-day moving average of $136.16. The company has a quick ratio of 1.00, a current ratio of 1.02 and a debt-to-equity ratio of 0.37. The firm has a market cap of $34.13 billion, a price-to-earnings ratio of 17.20, a PEG ratio of 0.89 and a beta of 1.02. Raymond James has a 12 month low of $104.24 and a 12 month high of $171.38.

Raymond James Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, January 16th. Investors of record on Thursday, January 2nd were given a $0.50 dividend. The ex-dividend date was Thursday, January 2nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.20%. This is a boost from Raymond James's previous quarterly dividend of $0.45. Raymond James's dividend payout ratio (DPR) is presently 20.60%.

Insider Activity at Raymond James

In other Raymond James news, insider Bella Loykhter Allaire sold 1,170 shares of the firm's stock in a transaction on Friday, November 29th. The stock was sold at an average price of $169.43, for a total value of $198,233.10. Following the sale, the insider now owns 80,421 shares of the company's stock, valued at approximately $13,625,730.03. This trade represents a 1.43 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Tashtego S. Elwyn sold 10,000 shares of Raymond James stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $159.47, for a total value of $1,594,700.00. Following the completion of the transaction, the insider now owns 32,688 shares in the company, valued at approximately $5,212,755.36. This represents a 23.43 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 64,621 shares of company stock valued at $10,729,488 over the last quarter. 0.54% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Raymond James

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Franklin Resources Inc. lifted its stake in Raymond James by 1.6% in the 3rd quarter. Franklin Resources Inc. now owns 568,070 shares of the financial services provider's stock valued at $73,940,000 after purchasing an additional 9,217 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Raymond James by 1.5% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 473,140 shares of the financial services provider's stock worth $57,941,000 after buying an additional 7,028 shares in the last quarter. Banque Cantonale Vaudoise bought a new position in shares of Raymond James in the 3rd quarter valued at $3,561,000. XTX Topco Ltd boosted its holdings in shares of Raymond James by 390.7% during the 2nd quarter. XTX Topco Ltd now owns 8,351 shares of the financial services provider's stock valued at $1,032,000 after acquiring an additional 6,649 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund grew its position in Raymond James by 109.3% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 111,462 shares of the financial services provider's stock worth $13,778,000 after acquiring an additional 58,200 shares during the last quarter. 83.83% of the stock is owned by institutional investors.

Raymond James Company Profile

(Get Free Report)

Raymond James Financial, Inc, a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments.

Further Reading

Earnings History and Estimates for Raymond James (NYSE:RJF)

Should You Invest $1,000 in Raymond James Right Now?

Before you consider Raymond James, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Raymond James wasn't on the list.

While Raymond James currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines